Can you take Wegovy with fibromyalgia?

Jump to: How Wegovy might help fibromyalgia symptoms | The pain-weight-fatigue cycle | What the inflammation evidence does and doesn’t show | Foods to focus on | Movement and physical activity | Looking after your mental health | Sleep and fibromyalgia | Wegovy vs Mounjaro for fibromyalgia | Medication interactions | Wegovy clinical data | Frequently asked questions | Take home message

You can take Wegovy with fibromyalgia.

There’s no known interaction between semaglutide (the medication in Wegovy) and fibromyalgia, and weight loss has been shown to improve pain, sleep, and physical function in people with the condition.⁴

A 2026 cohort study using U.S. health records found that people with fibromyalgia who were prescribed GLP-1 receptor agonists had lower rates of opioid use, pain-related diagnostic codes, and fatigue-related diagnostic codes over five years of follow-up compared with matched non-users.²

The study has important limitations, as outlined below, but it’s the first to examine GLP-1 medications specifically in fibromyalgia.

This article covers what the evidence does and doesn’t show, how to manage Wegovy alongside fibromyalgia symptoms, and practical guidance on food, movement, sleep, and mental health that’s relevant if you’re living with both conditions.

How Wegovy might help fibromyalgia symptoms

Fibromyalgia is a chronic condition where the nervous system processes pain signals in a way that amplifies them. This is sometimes called central sensitisation, where the brain and spinal cord become more sensitive to pain over time. It affects around 2-4% of the population and is more common in women.

The main symptoms are widespread pain, severe fatigue, sleep problems, and cognitive difficulties (often called ‘fibro fog’).

Obesity is significantly more common in people with fibromyalgia than in the general population.

A 2021 meta-analysis found that around 36% of people with fibromyalgia have obesity, and a further 30% are overweight.³

Higher body weight is also associated with worse pain, more disability, and lower quality of life.⁵

A 2012 randomised trial found that people with fibromyalgia who lost weight through a calorie-controlled diet had significant improvements in pain, sleep quality, and physical function compared with those who didn’t change their diet.⁴

A larger 2026 cohort study by Eshak and colleagues used US health records to compare around 48,000 people with fibromyalgia who had been prescribed GLP-1 receptor agonists with around 48,000 matched people with fibromyalgia who hadn’t.²

Over five years of follow-up:

• 57.7% of GLP-1 users had opioid prescriptions vs 67.7% of non-users
• 25.5% had fatigue-related diagnostic codes vs 33.6%
• 47.0% had chronic pain diagnostic codes vs 52.9%
• There was no significant difference in disability-related codes

These differences were statistically significant. The study covered all GLP-1 receptor agonists (mainly semaglutide and tirzepatide), not Wegovy specifically.

However, this research has several limitations. The study used diagnostic codes from medical records rather than validated fibromyalgia outcome measures, such as the Fibromyalgia Impact Questionnaire.

BMI remained higher in the GLP-1 group even after matching, so some residual differences between the groups stayed in.

A published comment letter raised concerns about potential differences in follow-up times between the two cohorts, which could have affected the results.

The authors describe this as the first study of its kind and say randomised trials are needed to confirm whether GLP-1 medications meaningfully change fibromyalgia symptoms.

The pain-weight-fatigue cycle

Chronic pain and fatigue make physical activity harder, leading to gradual weight gain.

Extra weight then increases the mechanical load on joints and soft tissues, which can worsen pain.

Disrupted sleep affects hormones that regulate appetite, making it harder to eat in ways that support a healthy weight.

Several medications used for fibromyalgia symptoms can also contribute to weight gain. Pregabalin, gabapentin, and amitriptyline all list weight gain as a common side effect.

By reducing appetite and supporting weight loss, Wegovy may help interrupt this pattern.

The 2012 weight loss trial found that even modest reductions in body weight led to measurable improvements in pain and physical function, and the larger Eshak cohort study above suggests similar benefits at the population level.

It’s worth noting that fatigue is also a common side effect of Wegovy, particularly in the first few weeks of treatment as you adjust to each dose increase.

If you already have fibromyalgia-related fatigue, it can be hard to tell what’s driving any new tiredness.

Speak to your prescriber if your fatigue worsens noticeably after starting or moving up a dose.

What the inflammation evidence does and doesn’t show

Some discussion of GLP-1 medications and fibromyalgia centres on inflammation.

It’s worth being clear about what the evidence actually shows, because the picture is often presented as more settled than it is.

What we know: semaglutide reduces C-reactive protein (CRP), a general marker of inflammation in the bloodstream.

An exploratory analysis of the STEP 1, 2, and 3 trials found that semaglutide 2.4 mg reduced CRP by around 39-48% compared with placebo in people with overweight or obesity.⁶

What’s less clear: whether this peripheral CRP reduction translates to changes in how the brain and spinal cord process pain.

The kind of inflammation proposed to play a role in fibromyalgia occurs in the nervous system itself, and CRP measured in the blood doesn’t reliably reflect what’s happening in the brain or spinal cord.

There’s some early animal research suggesting that GLP-1 medications might directly affect pain-processing pathways.

A 2025 study of semaglutide in rats with experimentally induced fibromyalgia-like symptoms found anti-inflammatory and pain-relieving effects in the nervous system.

Animal results don’t always translate to humans, and there are no human studies measuring central nervous system changes with GLP-1 medications in fibromyalgia.

The honest summary is that weight loss reduces inflammation; semaglutide reduces inflammation more than weight loss alone in some studies; whether either of these translates to meaningful changes in fibromyalgia pain mechanisms is currently a hypothesis rather than an established finding.

Foods to focus on while taking Wegovy with fibromyalgia

There’s no single ‘fibromyalgia diet’, but a growing body of evidence suggests that what you eat can influence pain, fatigue, and inflammation.

A 2024 randomised trial found that people with fibromyalgia who followed a personalised Mediterranean-style diet had significant improvements in pain, fatigue, anxiety, and quality of life after 16 weeks compared with those who didn’t change their diet.⁷

This aligns with Second Nature’s approach to nutrition, which centres on whole foods: a balanced plate of half vegetables, a quarter protein, a quarter complex carbohydrates, plus a serving of fat.

Protein at every meal

Protein helps preserve muscle mass during weight loss, which is particularly important when fatigue and reduced activity already increase the likelihood of muscle loss.

Good sources include chicken, turkey, fish, eggs, Greek yoghurt, beans, lentils, and tofu. Aim to fill roughly a quarter of your plate with protein at each meal.

Vegetables and fibre

Aim to fill half your plate with vegetables at meals. They provide fibre, vitamins, and antioxidants that support overall health.

Leafy greens, broccoli, peppers, tomatoes, and root vegetables like sweet potato all work well. Variety in what you eat is more important than focusing on any single ‘superfood’.

Complex carbohydrates

High-fibre carbohydrates are digested more slowly and provide a more gradual release of energy, helping avoid the energy crashes that can worsen fibromyalgia fatigue.

Choose from rolled oats, brown rice, sweet potato, quinoa, wholegrain bread, beans, and lentils. Fill roughly a quarter of your plate with these at main meals.

Healthy fats

Fat from whole foods supports nutrient absorption and helps you feel satisfied with smaller portions, which matters when Wegovy reduces your appetite.

Use extra virgin olive oil as your main cooking fat. Include avocado, nuts, and seeds regularly.

Oily fish (salmon, mackerel, sardines) at least twice a week provides omega-3 fatty acids, which have anti-inflammatory effects.

Make sure you eat enough

Wegovy significantly reduces appetite, and some people find it difficult to eat enough, particularly in the early weeks of treatment.

Eating too little increases the risk of micronutrient deficiencies and muscle loss.

We recommend eating three balanced meals a day based on nutrient-dense whole foods, even if you’re not hungry.

On days you’re struggling to eat, focus on foods that are easier to digest: Greek yoghurt with berries, a handful of nuts, scrambled eggs on sourdough, or a smoothie with yoghurt, milk, spinach, banana, and protein powder.

Batch cooking is a useful habit to introduce, as having meals ready to reheat means you’re less likely to skip meals or rely on ultra-processed convenience foods on days when fatigue is worse.

Foods that may worsen symptoms

Some people with fibromyalgia find that certain foods seem to trigger flare-ups. Common ones include alcohol, ultra-processed foods, and foods high in added sugar.

The evidence here is less robust than for anti-inflammatory eating patterns.

Rather than following strict elimination diets, it’s worth paying attention to whether specific foods seem to worsen your symptoms and discussing these patterns with your healthcare team.

Movement and physical activity

Physical activity is one of the most consistently recommended treatments for fibromyalgia.

EULAR’s fibromyalgia guidelines give exercise its strongest recommendation, the only treatment to reach that rating.⁸

Getting started and staying consistent is harder than the recommendations make it sound when you’re dealing with pain and fatigue every day.

Pacing comes first

People with fibromyalgia often experience ‘boom and bust’ cycles: doing too much on a good day, then crashing for days afterwards.

Pacing means deliberately doing less than you think you can on good days to avoid triggering a flare.

This can feel frustrating, but it’s one of the most effective strategies for building consistent activity over time.

Your physiotherapist or occupational therapist can help you work out a pacing plan.

Practical starting points

The most important thing is that any movement is better than none. You don’t need to hit specific targets to see benefits.

Research on habit formation suggests it takes an average of 66 days for a new behaviour to become automatic.¹¹

It helps to attach activity to something you already do: a five-minute walk after your morning coffee, some gentle stretching before bed.

If 10 minutes of walking feels manageable without triggering a flare the day after, try it consistently for a week or two before adding five more minutes.

Types of movement that tend to work well

Systematic reviews show benefits from both aerobic activity and resistance training in fibromyalgia.¹⁰ The type that works best is the one you’ll actually do regularly.

Options many people with fibromyalgia find manageable include:

• Walking, starting with whatever distance is comfortable
• Swimming or water-based exercise, where the water supports your body weight and reduces joint strain
• Gentle yoga or tai chi, which combine movement with breathing and relaxation
• Light resistance exercises using bodyweight or resistance bands
• Cycling on a stationary bike at a gentle pace

Aquatic exercise has particularly good evidence for fibromyalgia, with research showing improvements in pain, sleep quality, and physical function.

On days when pain or fatigue is worse, doing less or resting is fine.

What you do consistently over the long term will have a more positive impact on your symptoms than any single session will.

Looking after your mental health

Living with fibromyalgia takes a significant psychological toll.

A 2026 systematic review and meta-analysis found that around half of people with fibromyalgia experience symptoms of depression or anxiety.¹²

These figures aren’t surprising given what fibromyalgia involves: chronic pain that others can’t see, unpredictable flare-ups that disrupt plans, severe fatigue, and often a long road to diagnosis.

Fibro fog and cognitive difficulties

Cognitive difficulties are one of the most frustrating parts of fibromyalgia for many people.

Most people with the condition report problems with concentration, memory, and mental processing speed at some point.

‘Fibro fog’ tends to worsen during pain flare-ups, periods of poor sleep, and times of high stress.

It isn’t a sign of cognitive decline in the way that dementia is. It’s linked to how chronic pain and poor sleep affect brain function.

There’s no evidence that Wegovy directly affects cognitive symptoms.

Managing sleep, reducing stress where possible, and pacing your cognitive demands (not just physical ones) can all help.

The weight stigma dimension

For people living with both fibromyalgia and a higher body weight, weight stigma in healthcare settings is also an issue.

Some people describe feeling dismissed by clinicians who attribute their pain to their weight, or feeling judged for not being more active when exercise is genuinely difficult.

Fibromyalgia is a real neurological condition that exists regardless of body weight. Seeking care from clinicians who understand this can make a real difference to how supported you feel.

Therapy approaches with evidence

Acceptance and Commitment Therapy (ACT) has been studied in fibromyalgia and shows promise.

Unlike traditional cognitive-behavioural therapy (CBT), which focuses on changing thought patterns, ACT helps people develop psychological flexibility by learning to engage in valued activities even when pain is present.

Both ACT and CBT have evidence for chronic pain conditions. NICE recommends psychological support as part of fibromyalgia management.⁹

When to speak to your GP

If you notice persistent low mood, loss of interest in things you used to enjoy, increased anxiety, or thoughts of self-harm, speak to your GP. These are treatable, and getting support earlier makes a difference.

If you’re starting Wegovy and notice changes in your mood, mention this to your prescriber.

Semaglutide isn’t associated with mood changes in clinical trials, but the combination of a new medication, changing eating patterns, and managing a chronic condition can feel a lot at once.

Sleep and fibromyalgia

Sleep problems are one of the core symptoms of fibromyalgia.

People with the condition often describe non-restorative sleep, where they wake up tired even after a full night in bed.

Several things tend to improve fibromyalgia sleep over time:

• Weight loss, particularly if you also have sleep apnoea
• Regular daytime activity, even gentle
• Consistent sleep and wake times
• Reducing alcohol and caffeine, especially in the second half of the day
• A cool, dark, quiet bedroom

If you snore heavily, wake up gasping, or feel exhausted despite full nights of sleep, ask your GP about sleep apnoea screening.

Sleep apnoea is more common in people with obesity and is treatable, and treating it can improve fibromyalgia symptoms.

The 2012 weight loss trial in fibromyalgia found significant improvements in sleep quality alongside reductions in pain.⁴

Wegovy vs Mounjaro for fibromyalgia

Wegovy (semaglutide) and Mounjaro (tirzepatide) are the two GLP-1-based medications most commonly used for weight management in the UK. Neither has been studied specifically in fibromyalgia.

The Eshak cohort study covered all GLP-1 receptor agonists, so its findings apply to both medications rather than favouring one over the other.

In head-to-head weight-loss trials, tirzepatide produces slightly greater weight loss than semaglutide on average.

If the main mechanism by which GLP-1 medications help fibromyalgia is through weight loss, this could matter, but individual responses to both medications vary considerably.

Some people tolerate semaglutide better than tirzepatide and vice versa. Side-effect profiles are similar but not identical.

For most people with fibromyalgia, the choice between Wegovy and Mounjaro will come down to factors that aren’t specific to fibromyalgia: tolerability, cost, availability, prescriber recommendation, and personal preference.

There isn’t currently good evidence that either is clearly better for fibromyalgia symptoms specifically.

You can read more about Mounjaro and fibromyalgia in our dedicated guide.

Medication interactions to be aware of

There’s no direct interaction between semaglutide and the medications most commonly used for fibromyalgia (pregabalin, gabapentin, duloxetine, amitriptyline).¹

There are practical considerations worth discussing with your prescriber.

Wegovy slows the speed at which food and medications leave the stomach, which could theoretically affect how quickly oral medications are absorbed.¹

For most fibromyalgia medications, this isn’t clinically significant, but your prescriber may want to monitor your response.

Pregabalin, gabapentin, and amitriptyline all commonly cause weight gain.

If you’re taking Wegovy to manage your weight, it’s worth asking your prescriber whether your current fibromyalgia medications might be impacting your weight and whether alternatives could be appropriate.

NICE guidance on chronic primary pain (which includes fibromyalgia) actually advises against starting pregabalin or gabapentin for chronic primary pain.⁹

The recommended pharmacological options are antidepressants such as duloxetine or amitriptyline, although many people are already established on pregabalin or gabapentin from prescriptions started before this guidance came out.

Don’t change any medication without speaking to your prescriber first. Stopping pregabalin or gabapentin abruptly can cause withdrawal effects.

Wegovy is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition.¹³

Wegovy clinical data

Frequently asked questions

Will Wegovy help my fibromyalgia pain?

It might, particularly if you also have a higher body weight. The 2012 weight loss trial in fibromyalgia found significant pain reductions with weight loss.⁴

The 2026 Eshak cohort study found lower opioid use and fewer pain-related diagnostic codes in people with fibromyalgia who took GLP-1 medications.² Neither study guarantees individual results.

Can Wegovy make fibromyalgia fatigue worse?

In the early weeks of treatment, fatigue is a common side effect of Wegovy, particularly during dose increases.

Because fatigue is also a core symptom of fibromyalgia, the two can overlap.

Most people find that Wegovy-related fatigue settles as they adjust to each dose.

Should I change my fibromyalgia medications when starting Wegovy?

Don’t change anything without speaking to your prescriber first.

There are no direct interactions between Wegovy and common fibromyalgia medications, but your prescriber may want to review your overall treatment plan, particularly if any of your current medications cause weight gain.

Stopping pregabalin or gabapentin abruptly can cause withdrawal effects.

Is exercise safe with fibromyalgia?

Yes, and it’s one of the most strongly recommended treatments.

It’s recommended to start gently and build up gradually to avoid triggering symptom flares.

Water-based exercise is particularly well-tolerated. EULAR’s fibromyalgia guidelines give exercise their strongest recommendation.⁸

What diet is best for fibromyalgia?

A diet based on whole foods rich in vegetables, protein, complex carbohydrates, and healthy fats has the strongest evidence.

A 2024 trial showed significant improvements in fibromyalgia symptoms with this approach.⁷ Reducing ultra-processed foods and refined sugars is sensible regardless.

Will losing weight cure my fibromyalgia?

Fibromyalgia is a chronic condition, and weight loss isn’t a cure.

Research shows that losing weight can significantly improve pain, sleep, and physical function, particularly if you have a higher starting body weight.⁴

Many people find that weight loss makes their symptoms more manageable.

Can I take Wegovy if I’m on pregabalin or gabapentin?

Yes. There’s no known interaction between semaglutide and pregabalin or gabapentin.¹

Both medications can cause weight gain, so if you’re taking Wegovy specifically for weight management, it’s worth discussing your overall medication plan with your prescriber.

How long before I notice benefits for my fibromyalgia?

This varies. Weight loss with Wegovy is gradual, typically becoming noticeable over several months.

Some people notice improvements in energy and joint comfort earlier, even before significant weight loss.

Should I tell my rheumatologist or pain specialist that I’m starting Wegovy?

Yes. It’s good practice to keep your full medical team informed about new medications.

Your specialist may want to monitor whether weight loss affects your fibromyalgia symptoms and adjust your management plan as appropriate.

Take home message

You can take Wegovy with fibromyalgia. There are no known interactions, and research suggests that the weight loss Wegovy supports may reduce pain, improve sleep, and make daily activities more manageable.

The Eshak cohort study suggests GLP-1 medications may have additional benefits for fibromyalgia symptoms beyond weight loss, but the study has important limitations, and randomised trials specifically in fibromyalgia haven’t been done. Calling these benefits ‘proven’ would be overstating the evidence.

Alongside medication, focusing on a diet based on whole foods, building gradual movement habits, prioritising sleep, and looking after your mental health all support symptom management.

Work closely with your prescriber to manage the overlap between fibromyalgia symptoms and Wegovy side effects, particularly fatigue during dose increases.

Many fibromyalgia medications cause weight gain, so it’s worth reviewing your full treatment plan if weight management is the goal.

Second Nature’s medicated weight-loss programme combines Wegovy with support from registered dietitians and a structured habit-change programme.

It’s built around the balanced plate model (half vegetables, a quarter protein, a quarter complex carbohydrates, plus a serving of fat) and focuses on sustainable changes rather than restrictive dieting.

In a published study, active subscribers on Second Nature’s semaglutide-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss.¹⁴

References

1. Electronic Medicines Compendium. (2024). Wegovy 2.4 mg Summary of Product Characteristics
2. Eshak, N., Irani, A. and Sullivan, M. (2026). Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platform. Rheumatology, 65(2), keag033.
3. D’Onghia, M. et al. (2021). Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 51(2), 409-424.
4. Senna, M.K. et al. (2012). Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome. Clinical Rheumatology, 31(11), 1591-1597.
5. Gota, C.E. et al. (2015). Fibromyalgia and obesity: the association between body mass index and disability, depression, history of abuse, medications, and comorbidities. Journal of Clinical Rheumatology, 21(6), 289-295.
6. Verma, S. et al. (2022). Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials. eClinicalMedicine, 55, 101737.
7. Casini, I. et al. (2024). Mediterranean diet for fibromyalgia: a randomised controlled trial. Nutrients, 16(8), 1148.
8. Macfarlane, G.J. et al. (2017). EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases, 76(2), 318-328.
9. National Institute for Health and Care Excellence. (2021). Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE guideline NG193
10. Bidonde, J. et al. (2017). Aerobic exercise training for adults with fibromyalgia. Cochrane Database of Systematic Reviews, 6, CD012700.
11. Lally, P. et al. (2010). How are habits formed: Modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998-1009.
12. Jafari, M. et al. (2026). The global prevalence of depression and anxiety among fibromyalgia patients: a systematic review and meta-analysis. Journal of Affective Disorders, 393(Pt A), 120340.
13. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. NICE technology appraisal TA875
14. Richards, R. et al. (2025). A remotely delivered GLP-1RA-supported specialist weight management program in adults living with obesity: retrospective service evaluation. JMIR Formative Research, 9, e72577.